Snapdragon Chemistry Inc. was awarded a $691,878 firm fixed price definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to support research and development of a continuous manufacturing platform for COVID-19 mitigation efforts. The contract was awarded under Special Instructions 019 of the agency's Easy Broad Agency Announcement BAA-20-100-SOL-0002, which sought host-directed therapeutic candidates to aid long-term outcomes from lung injury. Snapdragon Chemistry will pursue safety review of candidates through Phase I and share resulting data and commercialization plans with the agency. No subcontractors or additional context were indicated.
Generated 12/29/23, 3:23 PM